Table 5.
Trial | Type of IDHE | Count of Sampled Dialysis Sessions 1 with and without IDHE |
Relative Risk (95% CI)** |
P-value 2 | |
---|---|---|---|---|---|
3× weekly Group |
6× weekly Group |
||||
Daily | No symptoms of hypotension | 2973 | 5945 | ||
1) Symptoms of hypotension led to lowering of UF rate or reduced blood flow | 218 | 293 | 1.26 (0.89, 1.77) |
0.18 | |
2a) Symptoms of hypotension led to administration of saline | 129 | 209 | 1.53 (1.11, 2.09) | 0.0086 | |
2b) Symptoms of hypotension led to lowering of UF rate and administration of saline. | 120 | 220 | |||
Nocturnal | No symptoms of hypotension | 1261 | 2159 | ||
1) Symptoms of hypotension led to lowering of UF rate or reduced blood flow | 43 | 38 | 0.85 (0.33, 2.17) | 0.74 | |
2a) Symptoms of hypotension led to administration of saline | 51 | 11 | 0.35 (0.18, 0.69) |
0.0024 | |
2b) Symptoms of hypotension led to lowering of UF rate and administration of saline. | 37 | 19 |
Dialysis session data recorded over periods of one week each month.
Top relative risk statistics and P-values reflect tests for whether patients in one treatment group were more likely to experience sessions associated with IDHEs which were treated by reducing the UF rate only (IDHE category 1). Bottom statistics reflect tests for whether patients in one treatment group were more likely to experience sessions associated with IDHEs which were treated with saline (IDHE categories 2a & 2b).